
Celldex Therapeutics CLDX
€ 22.37
2.35%
Quartalsbericht 2025-Q3
hinzugefügt 10.11.2025
Celldex Therapeutics P/CF 2011-2026 | CLDX
P/CF Jährlich Celldex Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.00833 | -0.0217 | -0.0193 | -0.0218 | -0.0159 | -0.711 | -0.844 | -3.54 | -2.85 | -7.76 | -18.5 | -29.3 | -8.39 | -4.9 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.00833 | -29.3 | -5.49 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
-2.96 | $ 2.45 | -1.61 % | $ 138 M | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Biogen
BIIB
|
6.73 | $ 172.45 | 0.5 % | $ 25.1 B | ||
|
Aptorum Group Limited
APM
|
-3.44 | $ 0.97 | 0.81 % | $ 5.29 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.65 | 2.82 % | $ 8.78 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
BioNTech SE
BNTX
|
70.7 | $ 117.57 | 1.37 % | $ 27.2 B | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
BioXcel Therapeutics
BTAI
|
-0.0746 | $ 1.79 | -1.64 % | $ 4.54 M | ||
|
BioLineRx Ltd.
BLRX
|
-57.4 | $ 2.94 | -5.16 % | $ 908 M | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
Catalyst Biosciences
CBIO
|
1.3 | $ 12.13 | -5.23 % | $ 799 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
-17.6 | $ 233.71 | -0.71 % | $ 5 B | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 9.81 | 0.56 % | $ 1.57 B | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
34.8 | $ 67.35 | 0.45 % | $ 9.01 B | ||
|
Compugen Ltd.
CGEN
|
2.98 | $ 2.06 | -1.67 % | $ 184 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-413 | $ 4.43 | -0.78 % | $ 9.64 B | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Cellectis S.A.
CLLS
|
-1.94 | $ 4.16 | -6.94 % | $ 116 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-14.6 | - | -15.15 % | $ 60.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
6.13 | $ 25.89 | -0.14 % | $ 1.25 B | ||
|
Coherus BioSciences
CHRS
|
-1.2 | $ 2.28 | 10.68 % | $ 215 M | ||
|
Amneal Pharmaceuticals
AMRX
|
6.19 | $ 13.48 | 0.67 % | $ 4.17 B | ||
|
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | ||
|
Athira Pharma
ATHA
|
-0.166 | - | - | $ 269 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-8.14 | $ 2.74 | 1.48 % | $ 17.2 M | ||
|
AstraZeneca PLC
AZN
|
13.6 | $ 94.2 | 1.34 % | $ 96.9 B | ||
|
Arena Pharmaceuticals
ARNA
|
-12.5 | - | -6.81 % | $ 3.04 B | ||
|
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M |